Semler Scientific reported a revenue increase of 6% to $14.0 million and a net income of $3.4 million for the first quarter of 2022. The company's cash position increased, and a stock buyback program was initiated.
Revenues were $14.0 million, an increase of 6% compared to $13.2 million.
Net income was $3.4 million, or $0.50 per basic share and $0.41 per diluted share, compared to $4.9 million, or $0.73 per basic share and $0.60 per diluted share.
Cash at March 31, 2022 increased to $38.4 million from $26.5 million.
Up to $20.0 million stock buyback program initiated.
Semler Scientific expects continued profitability and cash generation from operating activities, as well as increased spending to support anticipated growth in its business.
Analyze how earnings announcements historically affect stock price performance